Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction
Open Access
- 1 June 2006
- journal article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 189 (3) , 465-471
- https://doi.org/10.1677/joe.1.06582
Abstract
Thyroid hormones (THs) are essential for normal fetal development, with even mild perturbation in maternal thyroid status in early pregnancy being associated with neurodevelopmental delay in children. Transplacental transfer of maternal THs is critical, with increasing evidence suggesting a role for 3,3′,5-tri-iodothyronine (T3) in development and function of the placenta itself, as well as in development of the central nervous and other organ systems. Intrauterine growth restriction (IUGR) is associated with fetal hypothyroxinaemia, a factor that may contribute to neurodevelopmental delay. The recent description of monocarboxylate transporter 8 (MCT8) as a powerful and specific TH membrane transporter, and the association of MCT8 mutations with profound neurodevelopmental delay, led us to explore MCT8 expression in placenta. We describe the expression of MCT8 in normal human placenta throughout gestation, and in normal third-trimester placenta compared with that associated with IUGR using quantitative reverse transcriptase PCR. MCT8 mRNA was detected in placenta from early first trimester, with a significant increase with advancing gestation (P=0.007). In the early third trimester, MCT8 mRNA was increased in IUGR placenta compared with normal samples matched for gestational age (P<0.05), but there was no difference between IUGR and normal placenta in the late third trimester. Western immunoblotting findings in IUGR and normal placentae were in accord with mRNA data. MCT8 immunostaining was demonstrated in villous cytotrophoblast and syncytiotrophoblast as well as extravillous trophoblast cells from the first trimester onwards with increasingly widespread immunoreactivity seen with advancing gestation. In conclusion, expression of MCT8 in placenta from early gestation is compatible with an important role in TH transport during fetal development and a specific role in placental development. Altered expression in placenta associated with IUGR may reflect a compensatory mechanism attempting to increase T3 uptake by trophoblast cells.Keywords
This publication has 29 references indexed in Scilit:
- PTTG’s C-terminal PXXP motifs modulate critical cellular processes in vitroJournal of Molecular Endocrinology, 2004
- A Novel Syndrome Combining Thyroid and Neurological Abnormalities Is Associated with Mutations in a Monocarboxylate Transporter GeneAmerican Journal of Human Genetics, 2004
- Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone TransporterJournal of Biological Chemistry, 2003
- Placental Iodothyronine Deiodinase Expression in Normal and Growth-Restricted Human PregnanciesJournal of Clinical Endocrinology & Metabolism, 2003
- A potential role for PTTG/securin in the developing human fetal brainThe FASEB Journal, 2003
- Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the ChildNew England Journal of Medicine, 1999
- A novel transmembrane transporter encoded by the XPCT gene in Xq13.2Human Molecular Genetics, 1994
- Case-control study of intrapartum care, cerebral palsy, and perinatal deathBMJ, 1994
- Maternal-Fetal Transfer of Thyroxine in Congenital Hypothyroidism Due to a Total Organification Defect or Thyroid AgenesisNew England Journal of Medicine, 1989
- Regional anatomy of the term human placentaPlacenta, 1986